Article

COVID-19 pandemic challenges even the best of crisis management plans

Author(s):

Ophthalmology Times Staff Reports

Suber S. Huang, MD, MBA, CEO of the Retina Center of Ohio, Cleveland, offers advice for ophthalmologists in these uncharted waters in this interview with Ophthalmology Times®’ Sheryl Stevenson, group editorial director.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
Related Content
VivaVision Biotech receives positive preliminary comments from FDA on development of VVN461LD
June 10th 2025

VivaVision Biotech receives positive preliminary comments from FDA on development of VVN461LD

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

(Image credit: AdobeStock/upnowgraphics) Ophthalmology Times: AMD, AI, and the future of eye imaging: Inside the 2025 International SPECTRALIS Symposium
June 9th 2025

AMD, AI, and the future of eye imaging: Inside the 2025 International SPECTRALIS Symposium

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

University of Colorado Anschutz Medical Campus Ophthalmology Department receives $40 million gift
June 9th 2025

University of Colorado Anschutz Medical Campus Ophthalmology Department receives $40 million gift

GenEditBio doses first patient in investigator-initiated trial of GEB-101 for TGFBI corneal dystrophy
June 9th 2025

GenEditBio doses first patient in investigator-initiated trial of GEB-101 for TGFBI corneal dystrophy

© 2025 MJH Life Sciences

All rights reserved.